All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

In low- and middle-income countries (LMICs), the dual disease burden stemming from infectious diseases (IDs) and non-communicable diseases (NCDs) poses a challenge to population health and the health systems. Soil-transmitted helminths and schistosomes are estimated to infect over a billion individuals in LMICs \[[@pntd.0006332.ref001], [@pntd.0006332.ref002]\] and cause abdominal pain, diarrhea, poor cognitive development, malnutrition, and anemia. As a consequence of such symptoms, school and work performance is affected and physical activity levels compromised \[[@pntd.0006332.ref003]\]. Helminthiases are often chronic, a result of both under-treatment and re-infection. Soil-transmitted helminthiasis, schistosomiasis, and intestinal protozoa infection are intimately connected with poverty, partially explained by lack of clean water, sanitation, and hygiene \[[@pntd.0006332.ref004]\].

NCDs are gaining importance, also in LMICs \[[@pntd.0006332.ref005]\]. For example, the frequency of diabetes mellitus (DM) is rising worldwide, and South Africa is among the top five countries in Africa with an estimated DM prevalence of 9.2% \[[@pntd.0006332.ref006]\]. This can be attributed primarily to aging, population growth, increasing rates of unhealthy dietary habits, a sedentary lifestyle, and obesity. While NCDs and DM particularly affect older people, it is generally accepted that early life exposures contribute to the accumulation of molecular damage and a higher disease risk later in adulthood \[[@pntd.0006332.ref007]\].

Little is known about how common parasite infections affect glucose homeostasis and DM etiology, particularly at young age. It is conceivable that parasite infections influence the DM risk through different pathways and in opposite directions \[[@pntd.0006332.ref008]\]. On the one hand, parasite-induced alterations of immune regulatory networks, which have evolved to prolong survival in the human intestines, may stimulate anti-inflammatory pathways and decrease the risk of obesity-induced insulin resistance. Malnutrition, diarrhea and, as a result, low body weight related to chronic helminth infections may additionally decrease DM risk. On the other hand, a sedentary lifestyle and anemia have the potential to increase DM risk. Additionally, the mediating role of helminth-induced shifts in the gut microbiome composition remains to be determined \[[@pntd.0006332.ref009]\].

A limited number of recently reviewed epidemiologic studies with inconsistent results investigated the cross-sectional association of different IDs, including lymphatic filariasis \[[@pntd.0006332.ref010], [@pntd.0006332.ref011]\], schistosomiasis \[[@pntd.0006332.ref012]\], strongyloidiasis \[[@pntd.0006332.ref013], [@pntd.0006332.ref014]\], and soil-transmitted helminthiasis \[[@pntd.0006332.ref015], [@pntd.0006332.ref016]\] with DM or insulin sensitivity. In the present study, we followed up on these observations by studying the association of gastrointestinal tract infections due to helminths, intestinal protozoa, and the bacterium *Helicobacter pylori* with glycated hemoglobin (HbA1c) concentration in school children in the frame of the "Disease, Activity and Schoolchildren's Health" (DASH) study in Port Elizabeth, South Africa \[[@pntd.0006332.ref003], [@pntd.0006332.ref017]\]. The study provided detailed information on physical activity, fitness, and socioeconomic status (SES) to consider as confounding factors on gastrointestinal tract infection status, and intensity of helminth infections to study a possible dose-response relationship; and on the longitudinal course of HbA1c upon selective anthelmintic treatment.

Methods {#sec006}
=======

Ethics statement {#sec007}
----------------

Ethics approval was obtained from ethics committees in both Switzerland (EKNZ; reference no. 2014--179, approval date: 17 June 2014), and South Africa (study number H14-HEA-HMS002, approval date: 4 July 2014). Written informed consent from the parents/guardians of participating children as well as oral assent from the children were obtained prior to data collection.

Study setting and design {#sec008}
------------------------

A total of 1,009 grade-4 children aged 9--14 years from eight non-fee paying primary schools were recruited in various parts of Port Elizabeth in the south-eastern part of South Africa, as described before \[[@pntd.0006332.ref003], [@pntd.0006332.ref017]\]. The study was part of the 2-year longitudinal DASH study that consisted of three cross-sectional surveys. In each of the cross-sectional surveys, children's gastrointestinal infections and other health parameters were assessed, including HbA1c, anthropometry, levels of physical fitness, cognitive performance, and psychosocial health. After each survey, helminth-infected children were treated with a single 400 mg oral dose of albendazole. In schools where the prevalence of helminth infection was 20% or above, all children were treated regardless of infection status according to guidelines put forth by the World Health Organization (WHO) \[[@pntd.0006332.ref018]\]. Children with other infections (*Cryptosporidium* spp. and/or *Giardia intestinalis*) in combination with severe symptoms (e.g., bloody stool, diarrhea, abdominal pain, and any abnormal lung sounds) were referred to the nearest local health clinic for individual management.

The baseline cross-sectional survey took place in March 2015. The current study considers data from this baseline survey and the anthelmintic treatment follow-up examination in September/October 2015.

Inclusion and exclusion criteria {#sec009}
--------------------------------

Grade-4 primary school children of the selected schools were included in the study. Children with severe clinical signs and symptoms (e.g., severe fever, severe headache, dizziness, nausea, skin rashes, seizures, and diarrhea) or reported serious health problems, such as Crohn's disease, liver or kidney diseases, or who participated in any other study were excluded.

Procedures {#sec010}
----------

### Questionnaires and interviews {#sec011}

Standardized questionnaires available in both English and local languages (Afrikaans and Xhosa) were used to determine the SES of the children and their families. Volunteers fluent in relevant languages were trained to conduct these in-person interviews.

### Clinical and anthropometric assessment {#sec012}

Experienced nurses obtained a detailed medical history through physical examination of the whole body and evaluation of symptoms to assess current infections, anemia, jaundice, as well as signs and symptoms of protein energy malnutrition, general respiratory and gastrointestinal problems, allergies, and skin infections. Body temperature was measured using an infrared digital ear thermometer (TS7, Hi-Care International; Cape Town, South Africa). Blood pressure was measured once after the child had been seated for 5 min using validated oscillometric Omron digital blood pressure monitor (Omron M6 AC model; Hoofdoorp, Netherlands).

For the anthropometric measurements, shoes and sweaters were removed before standing on a digital weighting scale (Micro T7E electronic platform scale, Optima Electronics; George, South Africa). Body weight was measured once to the nearest 0.1 kg. Children's height was assessed with a Seca stadiometer (Surgical SA; Johannesburg, South Africa), whereby the child was standing with the back erect, heals touching the wall, and shoulders relaxed. Body height was taken to the nearest 0.1 cm.

### Stool and urine sampling for assessment of gastrointestinal tract infection {#sec013}

A sample of at least 15 g of early morning stool from every participant was collected in a container and transferred to a laboratory of the Nelson Mandela University (NMU) in Port Elizabeth for diagnostic work-up. Stool samples were visually examined for *Taenia* spp. proglottids, signs of blood, mucus, and diarrhea. Duplicate 41.7 mg Kato-Katz thick smears were prepared from each stool sample \[[@pntd.0006332.ref019]\] and examined under a microscope by two experienced laboratory technicians. The number of helminth eggs was counted and recorded for each species separately. Helminth egg counts were multiplied by a factor of 24 to obtain a proxy for infection intensity, expressed as the number of eggs per gram of stool (EPG), which was then categorized into light, moderate, and heavy infections using readily available cut-offs offered by WHO \[[@pntd.0006332.ref020]\]. For the detection of intestinal protozoa *C*. *parvum* and *G*. *intestinalis*, a Crypto-Giardia Duo-Strip rapid diagnostic test (RDT) was performed on the stool sample \[[@pntd.0006332.ref021]\]. For the discovery of the bacterium *H*. *pylori*, a Pylori-Strip RDT was applied \[[@pntd.0006332.ref022]\] (both tests are from CORIS, BioConcept; Gembloux, Belgium).

Children were also asked to provide a urine sample, which was transferred to the laboratory and analyzed on the same day. Visual inspection for macrohematuria was followed by testing for blood in urine using Hemastix strips (Siemens Healthcare Diagnostics GmbH; Eschborn, Germany), as a proxy for *Schistosoma haematobium* infection. A point-of-care circulating cathodic antigen (POC-CCA) urine cassette test (Rapid Medical Diagnostics; Cape Town, South Africa) was used for the diagnosis of *Schistosoma mansoni* infection \[[@pntd.0006332.ref023]\].

The infectious agents under the same taxonomy were grouped as trematodes (*S*. *mansoni* and *S*. *haematobium*), nematodes (*Ascaris lumbricoides*, *Enterobius vermicularis*, and *Trichuris trichiura*), intestinal protozoa (*G*. *intestinalis* and *C*. *parvum*), and bacteria (*H*. *pylori*) in the statistical analyses.

### HbA1c measurement {#sec014}

HbA1c reflects plasma glucose concentrations over an 8- to 12-week period. It is used as a convenient diagnostic indicator for DM, as no fasting is required to measure it. HbA1c concentrations were obtained by using the POC instrument Afinion (Alere Inc. Waltham; Waltham, MA, USA), which is based on boronate affinity separation and the use of fluorescence quenching, with results available after 3 min. This method meets the generally accepted performance criteria for HbA1c, as defined by the U.S. National Glycohemoglobin Standardization Program (NGSP), with no interference from HbC, HbS, HbE, and HbD traits results. All test cartridges for the Afinion test belonged to the specific lot number. Test cartridges were stored at 4°C during the study and were removed from the refrigerator a maximum of 120 min before the test. The tests were run when the temperature of the cartridges were in their optimal range (15--25°C). Ambient room temperature was measured on each test day to assure absence of temperature effects on HbA1c test results as a means of quality control. Patients with HbA1c ≥6.5%, the recommended cut-off for diagnosing DM \[[@pntd.0006332.ref024]\], were referred to DM care centers for confirmation and specific management.

### Hemoglobin (Hb) measurement {#sec015}

Hb concentration was measured with the HemoCue Hb 301 system (HemoCueAB; Ängelholm, Sweden) and the results were considered to the nearest 0.1 g/l.

Covariates information {#sec016}
----------------------

The SES was derived from housing characteristics and household assets ([S1 Table](#pntd.0006332.s003){ref-type="supplementary-material"}). The SES score of the households was categorized as poorest, poor, and least poor using the scale by Filmer and Pritchett to disaggregate the distribution of the scores \[[@pntd.0006332.ref025]\].

The age of individuals was grouped into five categories (8--9, 10, 11, 12 and \>12 years), according to the age distribution of the population in the study. The body mass index (BMI) was calculated as kg/m^2^ based on the measured height and weight. For physical activity, we used questionnaires on the frequency and duration of certain activities (how many days in a week the children were physically active for a total of at least 60 min, the traveling time from home to school, and numbers of exercising days and intensity of exercise in children's leisure time). The scores were summed up and equally categorized into tertiles: active, fair, and poor physical activity level according to the distribution of scores.

Cardiorespiratory fitness (VO~2~ max) is the maximum rate of oxygen consumption, as measured during incremental exercise. We estimated the individual VO~2~ max from the 20 m shuttle run test, which is the most widely used field test for determining cardiorespiratory fitness in children \[[@pntd.0006332.ref026], [@pntd.0006332.ref027]\].

Statistical analysis {#sec017}
--------------------

A complete case analysis was applied. Forty out of 882 participants at baseline moved or changed schools within the 6-month anthelmintic treatment follow-up, and hence, did not participate in the latter cross-sectional survey. Statistical analyses were performed with STATA version 14.1 (StataCorp; College Station, TX, USA). Statistical significance was defined as a two-sided p-value\<0.05.

Descriptive statistics include counts, percentages for categorical variables and, means, and standard deviations (SD) for continuous variables. The categorization of DM status by sex is described according to the American Diabetes Association cutoffs for HbA1c. The baseline prevalence of the different gastrointestinal tract infections is presented for the different schools separately. The characteristics of covariates at baseline are presented stratified for infected and non-infected children. To assess the independent association between gastrointestinal tract infections and HbA1c measurement (treated as continuous numerical data) at baseline, linear mixed regressions models with random intercepts for schools were computed. Models were *a priori* adjusted for factors previously shown to be associated with infections and glycemia or diabetes, and therefore with a potential role as confounders: age, sex, SES, Hb, height, weight, BMI, systolic and diastolic blood pressure, physical activity, VO~2~ max, and body temperature. As a sensitivity analysis, we also omitted weight, BMI, physical activity, VO~2~ max, anemia and blood pressure from the models as they are potential mediators of infection effects on glycemia or correlates of glycemia. All models were run (i) by adding each infection separately without excluding children with other infections; (ii) by adding each infection separately and excluding children with other infections; (iii) by adding all infection variables simultaneously and; and (iv) by adding groups of infections. We also assessed dose-response effects on HbA1c for infectious agents, especially *A*. *lumbricoides*, where data on intensity of infection was available. To assess the independent effect of anthelmintic treatment on changes in HbA1c level between baseline and the 6-month anthelmintic treatment follow-up among children from schools without lifestyle intervention and who were infected at baseline, linear mixed regression models with random intercepts for schools were built. Models were *a priori* adjusted for age, sex, SES, Hb, height, weight, BMI, diastolic and systolic blood pressure, physical activity, VO~2~ max, and body temperature, considering information from both time points, as appropriate. Longitudinal models were re-run among subjects infected at baseline but not at follow-up, to differentiate between the effect of the anthelmintic treatment itself and the effect of resolved infection on change in HbA1c. Models were also run for children infected with nematodes and for children with any gastrointestinal tract infection separately.

Results {#sec018}
=======

Complete data records including the baseline and 6-month anthelmintic treatment follow-up surveys were available from 842 children ([Fig 1](#pntd.0006332.g001){ref-type="fig"}). [Fig 2](#pntd.0006332.g002){ref-type="fig"} shows the distribution of HbA1c at baseline and at the 6-month follow-up for the total study sample of 842 children irrespective of the intervention that they obtained. There was a small shift towards lower HbA1c levels at follow-up (p\<0.001), reflecting the lifestyle intervention in some schools. The results of quality control tests underline the validity of the HbA1c data. First, HbA1c results did not depend on the day of examination (p = 0.222), body temperature (p = 0.327), or ambient temperature (p = 0.217) ([S1 Fig](#pntd.0006332.s002){ref-type="supplementary-material"}). Second, results from the weekly calibration with identical control 1 and control 2 are presented in [S2 Table](#pntd.0006332.s004){ref-type="supplementary-material"}. At baseline, the overall mean HbA1c level of participants was 5.79% with SD of 0.25. The prevalence of prediabetes and diabetes according to baseline is presented in [S3 Table](#pntd.0006332.s005){ref-type="supplementary-material"}. A high prevalence of preDM was observed with 605 (71.8%) of children having preDM HbA1c levels. Three children (0.4%) exhibited HbA1c results ≥6.5% at baseline and were offered diagnostic follow-up for DM. The characteristics of the study population and its univariate association with HbA1c are presented in [S4 Table](#pntd.0006332.s006){ref-type="supplementary-material"}.

![Children retained in the study sample for complete case analysis.](pntd.0006332.g001){#pntd.0006332.g001}

![Distribution of HbA1c measured at baseline and 6 month follow-up in the total study sample, irrespective of the intervention obtained(N = 842).](pntd.0006332.g002){#pntd.0006332.g002}

[Table 1](#pntd.0006332.t001){ref-type="table"} shows the prevalence of gastrointestinal tract infections in the study schools at baseline. *H*. *pylori* was the predominant infection (416 children with a positive RDT result, 49.4%). At the unit of the school, the prevalence of *H*. *pylori* ranged from 27% to 62%.

10.1371/journal.pntd.0006332.t001

###### Baseline prevalence (%) of gastrointestinal tract infections, stratified by schools.
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  Schools and infection status                                        School 1(N = 89)   School 2(N = 168)   School 3[^1^](#t001fn001){ref-type="table-fn"}(N = 81)   School 4[^1^](#t001fn001){ref-type="table-fn"}(N = 102)   School 5(N = 82)   School 6(N = 84)   School 7[^1^](#t001fn001){ref-type="table-fn"}(N = 143)   School 8[^1^](#t001fn001){ref-type="table-fn"}(N = 93)   Total N,%(842,100.0)
  ------------------------------------------------------------------- ------------------ ------------------- -------------------------------------------------------- --------------------------------------------------------- ------------------ ------------------ --------------------------------------------------------- -------------------------------------------------------- ----------------------
  **Nematodes(n,%)**                                                  **1,1.1**          **133,79.2**        **67,82.7**                                              **4,3.9**                                                 **1,1.2**          **4,4.8**          **42,29.4**                                               **9,9.7**                                                **261,31.0**
  *Ascaris lumbricoides*(%)                                           1.1                62.5                74.1                                                     1.0                                                       0                  3.6                25.9                                                      4.3                                                      **211,25.1**
  *Trichuris trichiura*(%)                                            0                  66.7                67.9                                                     0                                                         1.2                0                  2.1                                                       2.2                                                      **137,16.3**
  *Enterobius vermicularis*(%)                                        0                  1.2                 3.7                                                      2.0                                                       1.2                2.4                2.8                                                       4.3                                                      **18,2.1**
  **Trematodes(n,%)**                                                 **8,9.0**          **11,6.6**          **1,1.2**                                                **1,1.0**                                                 **6,7.3**          **5,6.0**          **9,6.3**                                                 **5,5.4**                                                **46,5.5**
  *Schistosoma mansoni*(%)                                            0                  3.0                 0                                                        1.0                                                       1.2                0                  0.7                                                       0                                                        **8,1.0**
  *Schistosoma haematobium*(%)[\*](#t001fn004){ref-type="table-fn"}   9.0                3.6                 1.2                                                      0                                                         6.1                6.0                5.6                                                       5.4                                                      **38,4.5**
  **Intestinal protozoa(n,%)**                                        **13,14.6**        **30,17.9**         **11,13.6**                                              **7,6.9**                                                 **11,13.4**        **9,10.7**         **24,16.8**                                               **9,9.7**                                                **114,13.5**
  *Cryptosporidium parvum*(%)                                         3.4                1.8                 1.2                                                      1.0                                                       4.9                4.8                4.2                                                       2.2                                                      **21,2.4**
  *Giardia intestinalis*(%)                                           11.2               16.1                12.4                                                     5.9                                                       9.8                9.5                14.0                                                      7.5                                                      **96,11.4**
  ***Helicobacter pylori***(%)                                        **62,69.7**        **111,66.1**        **50,61.7**                                              **53,52.0**                                               **35,42.7**        **23,27.4**        **42,29.4**                                               **40,43.0**                                              **416,49.4**

^1^ Schools without intervention related to health education, nutrition, and physical activity

N Number of children in each school

n Number of infected children in each school and parasite group

\**S*. *haematobium* infections only detected with hemastix strips

The second most common infections were the soil-transmitted helminths *A*. *lumbricoides* and *T*. *trichiura*. Two out of eight schools showed very high prevalence of *A*. *lumbricoides* infection (62.5% and 74.1%), there was a moderate infection prevalence in a third school (25.9%), while the prevalence in the five remaining schools were below 5%. High prevalence of *T*. *trichiura* infection was observed in the same two schools where the prevalence of *A*. *lumbricoides* prevalence was high (66.7% and 67.9%, respectively), while the prevalence of *T*. *trichiura* was below 3% in the remaining six schools.

In all schools, infection rates were low to very low or even undetectable for intestinal protozoa (*Cryptosporidium* spp. 1--5%; *G*. *intestinalis* 6--17%), the nematode *E*. *vermicularis* (1--5%), and the trematodes *S*. *mansoni* (1--3%; detected by POC-CCA urine cassette test) and *S*. *haematobium* (0%).

[Table 2](#pntd.0006332.t002){ref-type="table"} simply compares the characteristics of participants with and without a specific gastrointestinal tract infection. Except for *H*. *pylori*, the proportion of children with low SES was higher among infected children compared to their non-infected counterparts. Infections with nematodes and *G*. *intestinalis* were more common in males, whereas *C*. *parvum* infection was more common in females. Infected children were, on average, older than their non-infected peers. Nevertheless, children with an *A*. *lumbricoides*, *T*. *trichiura*, and *E*. *vermicularis* infection had lower height, weight, and BMI compared to non-infected children. However, children infected with *A*. *lumbricoides*, *T*. *trichiura*, and *H*. *pylori* reported higher physical activity, but did not differ with regard to cardiorespiratory fitness. Concerning anemia and HbA1c, no clear pattern of association was evident from the univariate analysis.

10.1371/journal.pntd.0006332.t002

###### Distribution of characteristics of participants at baseline, by presence or absence of specific gastrointestinal tract infections.
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  Covariates                        *A*.* lumbricoides*   *T*.* trichiura*   *E*.* vermicularis*   *S*.* mansoni*    *S*.* haematobium*   *C*.* parvum*    *G*.* intestinalis*   *H*.* pylori*                                                                                                                              
  --------------------------------- --------------------- ------------------ --------------------- ----------------- -------------------- ---------------- --------------------- --------------- ----------------- ---------------- ----------------- ---------------- ----------------- ---------------- ----------------- -----------------
  Low SES: N, %                     189,30.0              147,70.0           218,32.6              118,68.2          326,39.6             10,55.6          332,39.8              4,50.0          316,39.3          20,52.6          329,40.0          7,33.3           291,39.0          45,46.9          172,40.4          164,39.4
  Female: N, %                      322,51.4              94,45.5            342,51.4              74,42.7           409,50.1             7,38.9           412,49.9              4,50.0          392,48.8          24,63.1          401,48.8          15,71.4          374,50.1          42,43.8          205,48.4          211,51.4
  Age,years:N, mean,SD              631,10.7,0.972        211,11.2,0.865     669,10.7,0.987        173,11.2,0.789    824,10.8,0.969       18,10.9,1.017    834,10.8,0.970        8,11.6,0.721    804,10.8,0.953    38,11.2,1.239    821,10.8,0.972    21,10.8,0.905    746,10.8,0.964    96,11.1,0.994    426,10.8,1.012    416,10.9,0.926
  Height, cm: N, mean, SD           631,133.8,7.083       211,131.5,6.830    669,133.8,6.933       173,130.8,7.164   824,133.3,7.063      18,130.0,7.547   834,133.2,7.064       8,139.4,6.931   804,133.1,7.034   38,134.7,8.045   821,133.1,7.039   21,134.8,8.756   746,133.2,7.067   96,133.3,7.257   426,133.7,7.214   416,132.8,6.929
  Weight, kg: N, mean, SD           631,31.3,8.048        211,28.1,5.580     669,31.3,7.901        173,27.4,5.463    824,30.6,7.660       18,26.9,4.662    834,30.4,7.634        8,34.1,5.944    804,30.5,7.668    38,30.9,6.747    821,30.4,7.596    21,32.7,8.615    746,30.5,7.628    96,30.5,7.650    426,30.0,7.938    416,30.9,7.276
  BMI, kg/m^2^: N, mean, SD         631,17.3,3.254        211,16.1,2.102     669,17.3,3.213        173,15.9,1.930    824,17.0,3.066       18,15.8,1.626    834,17.0,3.048        8,17.6,3.108    804,17.0,3.084    38,16.9,2.168    821,17.0,3.057    21,17.7,2.602    746,17.0,3.054    96,17.0,3.010    426,3.2,3.186     416,2.9,2.898
  VO~2~ max,ml/kg/min: N,mean, SD   631,45.9,5.080        211,45.5,5.098     669,45.8,5.099        173,45.8,5.055    824,45.8,5.048       18,46.6,6.729    834,45.8,5.073        8,46.4,6.805    804,45.9,5.081    38,44.3,5.210    821,45.9,5.081    21,43.8,5.050    746,46.1,5.027    96,45.5,5.562    426,46.0,5.375    416,45.9,4.781
  Low physical activity: N,%        250,39.6              56,26.5            271,40.5              35,20.2           297,36.0             9,50.0           302,36.2              4,50.0          292,36.3          14,36.8          298,36.3          8, 38.1          274,36.7          32,33.3          176,41.3          130,31.3
  Hb, g/l,:N, mean, SD              631,12.3,0.948        211,11.9,0.916     669,12.3,0.963        173,11.9,0.834    824,12.2,0.948       18,12.1,0.108    834,12.2,0.949        8,12.3,0.112    804,12.2,0.947    38,12.5,0.989    821,12.2,0.946    21,12.3,0.112    746,12.2,0.964    96,12.3,0.842    426,12.3,0.959    416,12.2,0.939
  HbA1c %: N, mean, SD              631,5.8,0.245         211,5.7,0.255      669,5.8,0.243         173,5.7,0.270     824,5.8,0.249        18,5.7,0.266     834,5.8,0.250         8,5.9,0.225     804,5.8,0.250     38,5.8,0.229     821,5.8,0.249     21,5.8,0.264     746,5.8,0.245     96,5.8,0.284     426,5.8,0.246     416,5.8,0.253

N Number of children

The results from the multivariable linear regression models of the cross-sectional association of single or grouped infections with HbA1c are presented in [Table 3](#pntd.0006332.t003){ref-type="table"}. We observed a positive association between *H*. *pylori* infection and HbA1c, irrespective of adjustments for other infections (β = 0.040; 95% confidence interval (CI) 0.006--0.074). No significant association of HbA1c with any other infectious agent or infection group was observed. Omitting covariates from the multivariable regression models that are potential mediators of infection effects on glycemia (physical activity, physical fitness, weight, BMI, and anemia) or correlated outcomes (blood pressure) did not materially alter the results presented for the fully adjusted models ([S5 Table](#pntd.0006332.s007){ref-type="supplementary-material"}). Excluding children with DM at baseline or at the 6-month anthelmintic treatment follow-up did not materially alter the findings ([S6 Table](#pntd.0006332.s008){ref-type="supplementary-material"}). In addition, we were not able to show a statistically significant dose-response relationship between intensity of *A*. *lumbricoides* and *T*. *trichiura* infection and HbA1c levels, albeit adjusted HbA1c levels were highest in children with most intense infections ([S7 Table](#pntd.0006332.s009){ref-type="supplementary-material"}).

10.1371/journal.pntd.0006332.t003

###### Adjusted associations of infection with HbA1c at baseline.
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  -------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ -------------------------------------------- ------------ --------------- -------------------------------------------- ------------ ------------------
  \                                            **All with respective infection**[^**1**^](#t003fn002){ref-type="table-fn"}   **Only respective infection**[^**2**^](#t003fn003){ref-type="table-fn"}   **Mutually adjusted for other infections or groups**[^**3**^](#t003fn004){ref-type="table-fn"}                                                                                                                                       
  **Single infections and infection groups**                                                                                                                                                                                                                                                                                                                                                                                                

  **N**                                        **β**[\*](#t003fn001){ref-type="table-fn"}                                    **95% CI**                                                                **N**                                                                                            **β**[\*](#t003fn001){ref-type="table-fn"}   **95% CI**   **N**           **β**[\*](#t003fn001){ref-type="table-fn"}   **95% CI**   

  **Nematodes**                                842                                                                           -0.018                                                                    -0.069--0.032                                                                                    343                                          -0.039       -0.115--0.037   842                                          -0.027       -0.079--0.024

  *A*.* lumbricoides*                          842                                                                           -0.021                                                                    -0.070--0.029                                                                                    307                                          -0.039       -0.133--0.055   842                                          -0.029       -0.080--0.023

  *T*.* trichiura*                             842                                                                           0.000                                                                     -0.060--0.060                                                                                    280                                          0.061        -0.208--0.330   842                                          0.002        -0.061--0.066

  *E*.* vermicularis*                          842                                                                           -0.053                                                                    -0.164--0.058                                                                                    284                                          -0.079       -0.251--0.093   842                                          -0.057       -0.168--0.054

  **Trematodes**                               842                                                                           0.013                                                                     -0.058--0.084                                                                                    296                                          0.012        -0.097--0.120   842                                          0.012        -0.059--0.083

  *S*.* mansoni*                               842                                                                           0.033                                                                     -0.132--0.199                                                                                    278                                          0.069        -0.387--0.525   842                                          0.029        -0.137--0.195

  *S*.* haematobium*                           842                                                                           0.008                                                                     -0.070--0.086                                                                                    295                                          0.011        -0.102--0.123   842                                          0.006        -0.072--0.084

  **Protozoa**                                 842                                                                           -0.006                                                                    -0.052--0.041                                                                                    283                                          -0.126       -0.314--0.062   842                                          -0.005       -0.052--0.042

  *C*.* parvum*                                842                                                                           -0.020                                                                    -0.122--0.083                                                                                    283                                          -0.121       -0.310--0.067   842                                          -0.030       -0.133--0.074

  *G*.* intestinalis*                          842                                                                           0.005                                                                     -0.045--0.055                                                                                    305                                          0.001        -0.093--0.095   842                                          0.006        -0.045--0.057

  ***H*.* pylori***                            **842**                                                                       **0.040**                                                                 **0.006--0.074**                                                                                 488                                          0.041        -0.003--0.085   **842**                                      **0.041**    **0.007--0.075**

  **Nematode infections**                      **All with respective infection**[^**1**^](#t003fn002){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                  

  **N**                                        **β**[\*](#t003fn001){ref-type="table-fn"}                                    **95% CI**                                                                                                                                                                                                                                                                                                     

  Only nematodes                               842                                                                           -0.057                                                                    -0.124--0.011                                                                                                                                                                                                                        

  Nematodes and other infections               842                                                                           0.013                                                                     -0.046--0.070                                                                                                                                                                                                                        

  Only other infections                        842                                                                           0.016                                                                     -0.024--0.055                                                                                                                                                                                                                        
  -------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ -------------------------------------------- ------------ --------------- -------------------------------------------- ------------ ------------------

\* Beta coefficients reflect the adjusted mean difference HbA1c (%) between children with and without the respective infection. Differences that are statistically significantly different (p\<0.05) are marked in bold.

^1^Single and group infection models as well as nematode infection models are adjusted for school age, sex, socioeconomic status (SES), hemoglobin (Hb) level, height, weight, BMI, systolic and diastolic blood pressure, physical activity, physical fitness, body temperature on the day of the HbA1c test

^2^Children with other infections are excluded from this analysis

^3^Mutually adjusted models include either all single infections or all infection groups; *H*. *pylori* is included in single infection and infection group models

Results pertaining to the association between albendazole treatment and change in HbA1c level at the 6-month treatment follow-up are presented in [Table 4](#pntd.0006332.t004){ref-type="table"}. The analysis is restricted to children from schools not subjected to lifestyle interventions given the observed slight decrease in HbA1c in the total study sample. Furthermore, only children with any infection or with nematode infection at baseline, respectively, were included. The regression analyses point to statistically non-significant increases in HbA1c concentrations at the 6-month treatment follow-up. The findings from multivariable regression model excluding covariates that could be potential mediators of infection effects on glycemia or correlated outcomes (weight, BMI, anemia, physical activity, physical fitness, and blood pressure) point to generally weaker and still statistically non-significant results ([S8 Table](#pntd.0006332.s010){ref-type="supplementary-material"}).

10.1371/journal.pntd.0006332.t004

###### Adjusted[^1^](#t004fn001){ref-type="table-fn"} estimate of average change in HbA1c (follow-up minus baseline) among children infected at baseline and visiting schools without lifestyle intervention.

![](pntd.0006332.t004){#pntd.0006332.t004g}

  Infections exposures                                                                                                               N     Estimate average change in HbA1c (%)   95% CI
  ---------------------------------------------------------------------------------------------------------------------------------- ----- -------------------------------------- ---------------
  **Nematode infections**                                                                                                                                                         
  All subjects with a nematode infection at baseline, adjusted for the presence of infection of any type at baseline and follow-up   414   0.049                                  -0.018--0.117
  Subjects with a nematode infection at baseline, but without any infection at follow-up                                             217   0.025                                  -0.008--0.108
  **Any infection**                                                                                                                                                               
  All subjects with any infection at baseline, adjusted for the presence of infection at follow-up                                   260   0.070                                  -0.008--0.148
  Subjects with any infection at baseline, but without any infection at follow-up                                                    103   0.054                                  -0.055--0.164

^1^All models were adjusted for schools, age, sex, socioeconomic status (SES), hemoglobin (Hb) level, weight, height BMI, physical activity, VO~2~ max, and body temperature, systolic and diastolic blood pressure at baseline and follow-up

Discussion {#sec019}
==========

To our knowledge this is the first investigation examining the cross-sectional association of a broad spectrum of gastrointestinal tract infections with glycemia in school-aged children and assessing the impact of anthelmintic treatment on the change in HbA1c values. We observed a positive association between *H*. *pylori* infection and HbA1c, while no statistically significant relationship was observed with any other type of infection.

Some animal experiments \[[@pntd.0006332.ref028]\] and human epidemiologic studies \[[@pntd.0006332.ref010], [@pntd.0006332.ref011], [@pntd.0006332.ref013], [@pntd.0006332.ref015]\] have shown helminth infections to lower the blood sugar level and inhibit the development of type 1 DM as well as type 2 DM. An inverse relationship between lymphatic filariasis and both type 1 and type 2 DM was reported from India \[[@pntd.0006332.ref010], [@pntd.0006332.ref011]\]. Having a previous schistosome infection exhibited a strong protective effect against DM in the People's Republic of China \[[@pntd.0006332.ref012]\]. *Strongyloides stercoralis* infection seemed to be associated with a reduced risk of type 2 DM in adult Australians \[[@pntd.0006332.ref013]\]. Soil-transmitted helminth infections were linked with an improvement of insulin sensitivity in Indonesia \[[@pntd.0006332.ref015]\]. Diabetic patients in Turkey were found to have a lower prevalence of parasitic disease than their healthy counterparts \[[@pntd.0006332.ref016]\]. In contrast, a positive association was found between *S*. *stercoralis* infection and DM in Brazil, where it was also found that such infections were associated with a high mortality risk among poorly controlled DM patients \[[@pntd.0006332.ref014]\]. A study conducted by Hakim and colleagues reported a high rate of *G*. *intestinalis* infection among DM patients \[[@pntd.0006332.ref029]\]. For trematode infections, positive association with HbA1c concentrations were reported from several studies \[[@pntd.0006332.ref012], [@pntd.0006332.ref030], [@pntd.0006332.ref031]\]. The cross-sectional nature of these studies precludes casual inference.

*H*. *pylori* is one of the most common human pathogens causing gastrointestinal inflammation. Potential underlying mechanisms linking *H*. *pylori* infection and HbA1c levels and DM may include a disturbance of glucose and lipid absorption by the inflamed gastrointestinal tissue. *H*. *pylori* infections may also alter host metabolic homeostasis by affecting appetite regulation and energy expenditure through altered balance of ghrelin and leptin secretion, leading to over-eating and metabolic syndrome pathogenesis. The mediating role of gut microbiota alterations remains unknown \[[@pntd.0006332.ref032]\]. The reported associations between *H*. *pylori* infection and DM remain inconsistent. The positive association reported among school children in the present study corroborates findings from two large cross-sectional national surveys conducted by Chen and Blaser in American population samples (one aged ≥18 years and one aged ≥3 years) and a Taiwanese study in adults, which all found that *H*. *pylori* infections were associated with higher mean HbA1c levels \[[@pntd.0006332.ref033], [@pntd.0006332.ref034]\]. Several smaller outpatient clinic or hospital based studies in Turkey, Pakistan, and Qatar among adults aged 18 years and above showed a higher prevalence of *H*. *pylori* infection in diabetic patients than non-DM control groups \[[@pntd.0006332.ref035]--[@pntd.0006332.ref037]\]. Other studies failed to find a positive association between *H*. *pylori* and HbA1c or DM \[[@pntd.0006332.ref038]--[@pntd.0006332.ref040]\].

In fact, DM patients were found to have higher rates of *H*. *pylori* eradication therapy according to national health insurance data from Taiwan. *H*. *pylori* eradication treatment success was found to be lower in DM compared to non-DM patients \[[@pntd.0006332.ref041], [@pntd.0006332.ref042]\]. Future intervention studies for the treatment of *H*. *pylori* should systematically consider changes in glycemia to shed light on the potential etiologic role of *H*. *pylori* in DM development. Some studies indicated an improvement of mean HbA1c and insulin resistance in patients with type 2 DM after *H*. *pylori* treatment \[[@pntd.0006332.ref043], [@pntd.0006332.ref044]\].

We did not observe a statistically significant increase in HbA1c after anthelmintic treatment with albendazole in children harboring nematode infections at baseline, possibly as a result of sample size limitations. The observed direction of the effect is in line with the reported shift towards a Th2 response in helminth-infected individuals. A number of clinical trials with helminth or helminth antigen therapy have reported promising results in inflammatory bowel diseases \[[@pntd.0006332.ref045], [@pntd.0006332.ref046]\], multiple sclerosis \[[@pntd.0006332.ref047]\], rheumatoid arthritis \[[@pntd.0006332.ref048]\]. After deworming, which triggers several hyper-inflammatory processes and shifts immune responses from Th2 to Th1, groups of children treated with either albendazole or mebendazole (against soil-transmitted helminthiasis) or praziquantel (against schistosomiasis) had a higher positive response to the skin-prick test and allergy related symptoms \[[@pntd.0006332.ref049], [@pntd.0006332.ref050]\]. Nevertheless, other studies emphasized that anthelmintic treatment did not have an effect on clinical eczema and asthmatic severity scores \[[@pntd.0006332.ref051], [@pntd.0006332.ref052]\].

Given that in our study the highest increase in HbA1c after albendazole treatment was observed in children with non-nematode parasite infection, additional research is needed to understand the effect of the anthelmintic drugs on human glucose metabolism. Yet, our results are aligned with the first publication from a randomized placebo-controlled trial in Indonesia, which showed no effect of albendazole treatment on insulin resistance \[[@pntd.0006332.ref053]\].

Our study has several strengths. First, the study population exhibited sufficient prevalence range for at least some of the infectious agents investigated to allow for efficient interrogation of the study objective. Second, the detailed characterization of children allowed us to assess independent associations of parasite infections with glycemia and limiting residual confounding. To analyze the SES of study participants, we chose multiple correspondence analysis (MCA) based on household characteristics and assets ownership over more traditional methods thereby minimizing measurement error related to the different calculation methods of income and consumption, recall bias, and seasonal variation of income and expenditure. Third, we used internationally certified HbA1c testing (Alere Technologies), regularly calibrated with standard control procedure. Ehehalt et al. showed that the measurement of HbA1c was a reliable criterion for children and adolescents to diagnose the onset of childhood type 1 DM \[[@pntd.0006332.ref054]\]. In addition, the POC HbA1c test is an accepted screening instrument for pre-DM and type 2 DM \[[@pntd.0006332.ref055], [@pntd.0006332.ref056]\]. We carefully evaluated potential measurement error in HbA1c in the light of the observed high prevalence of pre-DM. We demonstrated the absence of correlations with external temperature, body temperature, and examination date. In addition, all models were adjusted for the concentration of Hb, a potentially important confounder, which was assessed with the widely used HemoCue Hb 301 system.

We also acknowledge some limitations of our study. Reverse causation remains a problem related to the cross-sectional nature of our main analysis. The low prevalence for some infections limited statistical power for the analyses. The association between *H*. *pylori* infection and HbA1c is no longer statistically significant if the p-values are adjusted for the number of infections investigated (n = 8). Additionally, the co-infections \[[@pntd.0006332.ref003]\] may in part mask opposite effects of different parasites on HbA1c. Examining only one stool sample has a low diagnostic accuracy due to the day-to-day and intra-specimen variation in helminth egg output. To partially remedy this shortcoming, test specificity was increased by preparing duplicate Kato-Katz thick smears from each stool sample. We observed a very high rate of preDM in the children studied, which may limit the generalizability of the observed associations. Despite the fact that the Alere HbA1c testing is minimally affected by hemoglobinopathies, we cannot assess any influence in the absence of genotyping results. Selection bias related to the complete case analysis approach cannot be excluded but the very high participation rate at baseline and the 6-month anthelmintic treatment follow-up (5% drop-out rate), and the relatively low rate of children not providing stools (15%) are unlikely to have substantially altered the results.

In conclusion, the positive cross-sectional association of *H*. *pylori* infections with glycemia is consistent with a potential role of this highly prevalent bacterium in DM in LMICs. The direction and causality of the association warrants further scientific inquiry in the context of longitudinal studies and biobanks that focus on specific parasites and integrate immunity as well as other biomarkers to improve mechanistic understanding of parasite-glycemia associations and the potential impact of deworming programs on DM prevalence.
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